Bioretec Ltd BRETEC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BRETEC is a good fit for your portfolio.
News
-
Bioretec Ltd's Annual Report and Financial Statements 2023 published
-
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage
-
Inside information: Bioretec's European market authorization for RemeOs trauma screw has proceeded to expert panel evaluation, the approval is estimated during the Q2 2024
-
Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory
Trading Information
- Previous Close Price
- €2.70
- Day Range
- €2.64–2.70
- 52-Week Range
- €2.02–2.90
- Bid/Ask
- €2.64 / €2.70
- Market Cap
- €54.91 Mil
- Volume/Avg
- 160 / 36,168
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 15.39
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bioretec Ltd is a medical device company focusing on the development of safe, and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used world wide and continue to further develop materials and products for high-load-bearing clinical applications. Some of its brands include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 37
- Website
- https://www.bioretec.com
Comparables
Valuation
|
Metric
|
BRETEC
|
06639
|
6523
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 5.91 |
Price/Book Value | 6.41 | 1.74 | 1.15 |
Price/Sales | 15.39 | 1.85 | 0.41 |
Price/Cash Flow | — | 21.40 | 3.77 |
Price/Earnings
BRETEC
06639
6523
Financial Strength
|
Metric
|
BRETEC
|
06639
|
6523
|
|---|---|---|---|
Quick Ratio | 4.86 | 1.81 | 0.82 |
Current Ratio | 5.34 | 2.21 | 1.31 |
Interest Coverage | −3.54 | −2.38 | −0.43 |
Quick Ratio
BRETEC
06639
6523
Profitability
|
Metric
|
BRETEC
|
06639
|
6523
|
|---|---|---|---|
Return on Assets (Normalized) | −44.23% | −2.01% | 1.01% |
Return on Equity (Normalized) | −56.73% | −3.78% | 4.11% |
Return on Invested Capital (Normalized) | −40.73% | −2.01% | 4.17% |
Return on Assets
BRETEC
06639
6523
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tmzcpqw | Wmmjv | $185.5 Bil | |
SYK
| Stryker Corp | Hwsmvsyc | Dspfg | $128.2 Bil | |
MDT
| Medtronic PLC | Nqqlmlspm | Jggkz | $106.7 Bil | |
BSX
| Boston Scientific Corp | Kslwrbkrk | Ryzjqk | $99.0 Bil | |
DXCM
| DexCom Inc | Stlqtwlyym | Vbjq | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Cqgpttmv | Svprw | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Kfgpzlvl | Nkygf | $24.9 Bil | |
ALGN
| Align Technology Inc | Zlbnvqb | Tldhwk | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Hglblfh | Cklxxd | $18.9 Bil | |
PODD
| Insulet Corp | Zjwmpdpt | Czvjlw | $11.7 Bil |